Proteome analysis during a new chondrogenesis model from mesenchymal stem cells of human umbilical cord stroma

Comunicaciones a congreso

La colaboración interinstitucional en la producción científica española en Enfermería: análisis de redes sociales

Los objetivos del trabajo son analizar la producción científica española en el área de Enfermería, definir su evolución temporal, su distribución geográfica e institucional y observar la colaboración institucional. Metodo: Se analiza una exhaustiva muestra de producción científica española de enfermería extraida de la base de datos multidisciplinar SciVerse Scopus Resultados: La producción científica enfermera española crece a lo largo del tiempo, La tasa de colaboración es de 3,7 autores por trabajo y el 61% de los autores solo publican un trabajo. Barcelona y Madrid son las provincias con mayor nº de autores y la mayoría pertenecen al ámbito hospitalario seguido del Universitario Conclusiones: Se apunta la necesidad de utilizar bases de datos internacionales para investigación, docencia y asistencia, además de los recursos de información especializada nacionales. Se confirma la escasa colaboración con instituciones extranjeras

Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study

Background: Premorbid metabolic syndrome (pre-MetS) is a cluster of cardiometabolic risk factors characterised by central obesity, elevated fasting glucose, atherogenic dyslipidaemia and hypertension without established cardiovascular disease or diabetes. Community pharmacies are in an excellent position to develop screening programmes because of their direct contact with the population. The main aim of the study was to determine the prevalence of pre-MetS in people who visited community pharmacies for measurement of any of its five risk factors to detect the presence of other risk factors. The secondary aims were to study the presence of other cardiovascular risk factors and determine patients" cardiovascular risk. Methods: Cross-sectional, descriptive, multicentre study. Patients meeting selection criteria aged between 18 and 65 years who visited participating community pharmacies to check any of five pre-MetS diagnostic factors were included. The study involved 23 community pharmacies in Catalonia (Spain). Detection criteria for pre-MetS were based on the WHO proposal following IDF and AHA/NHBI consensus. Cardiovascular risk (CVR) was calculated by Regicor and Score methods. Other variables studied were smoking habit, physical activity, body mass index (BMI), and pharmacological treatment of dyslipidemia and hypertension. The data were collected and analysed with the SPSS programme. Comparisons of variables were carried out using the Student"s T-test, Chi-Squared test or ANOVA test. Level of significance was 5% (0.05). Results: The overall prevalence of pre-MetS was 21.9% [95% CI 18.7-25.2]. It was more prevalent in men, 25.5% [95% CI 22.1-28.9], than in women, 18.6% [95% CI 15.5-21.7], and distribution increased with age. The most common risk factors were high blood pressure and abdominal obesity. About 70% of people with pre-MetS were sedentary and over 85% had a BMI ≥25 Kg/m2 . Some 22.4% had two metabolic criteria and 27.2% of patients with pre-MetS had no previous diagnosis. Conclusions: The prevalence of pre-MetS in our study (21.9%) was similar to that found in other studies carried out in Primary Care in Spain. The results of this study confirm emergent cardiometabolic risk factors such as hypertension, obesity and physical inactivity. Our study highlights the strategic role of the community pharmacy in the detection of pre-MetS in the apparently healthy population

Adherencia al tratamiento con fármacos moduladores de la enfermedad sintéticos en la artritis reumatoide. Resultados del estudio OBSERVAR

[Abstract] Background: Treatment compliance with disease-modifying antirheumatic drugs (DMARD) is essential to achieve the therapeutic goals in rheumatoid arthritis (RA). However, despite the need for good compliance, there is evidence that patients with RA frequently fail to use DMARD for the control of RA. Thus, the main objective of the OBSERVAR study is to evaluate the reasons for the lack of therapeutic adherence to synthetic DMARD in these patients. Patients and methods: A Delphi process involving 18 randomly selected Spanish rheumatologists determined the level of agreement with 66 causes of noncompliance selected from the literature in relation to synthetic DMARD in RA. Results: The reasons for noncompliance were consistent in 75.7%, although 3 reasons (4.5%) were highly consistent: 1) not knowing what to do in the case of an adverse event with DMARD; 2) not having undergone adherence screening by health personnel for early detection of "noncompliant patients"; and 3) not having undergone interventions or strategies that improve adherence. Conclusion: In order to improve adherence to RA treatment with synthetic DMARD, the patient should be adequately informed of each new treatment introduced, the patient's compliance profile should be incorporated into the clinical routine and the patient's motivation for therapeutic compliance be reinforced through the methods available to us.[Resumen] Introducción. La cumplimentación del tratamiento modificador de la enfermedad es esencial para alcanzar los objetivos terapéuticos en la artritis reumatoide (AR). Sin embargo, y a pesar de la necesidad de una buena adherencia, existe evidencia de que muchos pacientes con AR no cumplen adecuadamente con la prescripción del tratamiento indicado con fármacos moduladores de la enfermedad de acción lenta (FAME) sintéticos o convencionales. Conscientes de la importancia de este hecho, el estudio sobre observancia terapéutica en AR (estudio OBSERVAR) tiene como objetivo principal valorar los motivos de la falta de adherencia terapéutica a los FAME sintéticos en estos pacientes. Pacientes y métodos. Mediante un proceso Delphi entre 18 reumatólogos españoles seleccionados aleatoriamente se determinó el grado de acuerdo con 66 causas de incumplimiento seleccionadas de la bibliografía, en relación con los FAME sintéticos en la AR. Resultados. Los motivos de incumplimiento fueron consistentes en el 75,7%, si bien 3 razones (4,5%) destacaron como muy consistentes: 1) desconocer qué hacer cuando se sufre un acontecimiento adverso con el FAME; 2) no llevar a cabo métodos de cribado de la adherencia por el personal sanitario para detectar a los «pacientes incumplidores» de forma temprana y 3) no aplicar intervenciones o estrategias que mejoren la adherencia terapéutica. Conclusión. Para mejorar la adherencia al tratamiento de la AR con FAME sintéticos se debe informar al paciente de cada tratamiento nuevo introducido, incorporar el perfil de cumplimiento del paciente en la rutina clínica, y reforzar la motivación del paciente al cumplimiento terapéutico mediante los métodos a nuestro alcance

Drug delivery from liposomes in different biorelevant media

Liposomes provide ideal vesicular systems for controlled release and vectorization of drugs through pulmonary administration, due to their similarity to cell membranes and their great versatility./nSildenafil citrate, represents an optimal model of drug to be incorporated into these lipid vesicles for the treatment of pulmonary hypertension./nThe objective of the work was to characterize the behavior of liposomes loaded with sildenafil and evaluate the transfer of the drug in different bio-resistant media./nLiposomes of two sizes (0.45 and 0.20 microns) were developed by sonication. Subsequently, the drug release test was carried out in different biorelevant media (simulated plasma fluid SBF, simulated pulmonary fluid SPF and PBS)./nAccording to the results obtained, a more sustained and consistent rate of release of the drug was observed over time in the case of liposomes, regardless of the medium. In PBS and SPF media, a greater amount of drug was released from the larger liposomes (0.45 microns), however, in the SBF the transfer kinetics of both liposome sizes (0.45µm and 0.20 µm) are very similar, with no significant differences in the time or amount of drug releasedLos liposomas constituyen sistemas vesiculares ideales para la liberación controlada y vectorización de fármacos a través de su administración pulmonar, debido a su similitud con las membranas celulares y su gran versatilidad./nEl citrato de sildenafilo, representa un óptimo modelo de fármaco para ser incorporado en estas vesículas lipídicas para el tratamiento de la hipertensión pulmonar./nEl objetivo del trabajo fue caracterizar el comportamiento de los liposomas cargados con sildenafilo y evaluar la cesión del fármaco en distintos medios biorrelevantes./nSe elaboraron liposomas de dos tamaños (0.45 y 0.20 micras) mediante sonicación. Posteriormente se llevó a cabo el ensayo de liberación del fármaco en diferentes medios biorrelevantes (fluido plasmático simulado SBF, fluido pulmonar simulado SPF y PBS)./nSegún los resultados obtenidos se observó una velocidad de liberación del fármaco más sostenida y constante a lo largo del tiempo en el caso de los liposomas, independientemente del medio. En los medios PBS y SPF, se liberó una mayor cantidad de fármaco desde los liposomas con mayor tamaño (0,45 µm), sin embargo, en el SBF las cinéticas de cesión de ambos tamaños de liposomas (0,45 y 0,20 µm) son muy similares, no encontrándose diferencias significativas en el tiempo o cantidad de fármaco liberada

Enzymatic fine-tuning for 2-(6-hydroxynaphthyl) β-d-xylopyranoside synthesis catalyzed by the recombinant β-xylosidase BxTW1 from Talaromyces amestolkiae

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.-- et al.[Background]: Glycosides are compounds displaying crucial biological roles and plenty of applications. Traditionally, these molecules have been chemically obtained, but its efficient production is limited by the lack of regio- and stereo-selectivity of the chemical synthesis. As an interesting alternative, glycosidases are able to catalyze the formation of glycosides in a process considered green and highly selective. In this study, we report the expression and characterization of a fungal ß-xylosidase in Pichia pastoris. The transglycosylation potential of the enzyme was evaluated and its applicability in the synthesis of a selective anti-proliferative compound demonstrated. [Results]: The ß-xylosidase BxTW1 from the ascomycete fungus Talaromyces amestolkiae was cloned and expressed in Pichia pastoris GS115. The yeast secreted 8 U/mL of ß-xylosidase that was purified by a single step of cation-exchange chromatography. rBxTW1 in its active form is an N-glycosylated dimer of about 200 kDa. The enzyme was biochemically characterized displaying a K m and k cat against p-nitrophenyl-ß-d-xylopyranoside of 0.20 mM and 69.3 s¿1 respectively, and its maximal activity was achieved at pH 3 and 60 °C. The glycan component of rBxTW1 was also analyzed in order to interpret the observed loss of stability and maximum velocity when compared with the native enzyme. A rapid screening of aglycone specificity was performed, revealing a remarkable high number of potential transxylosylation acceptors for rBxTW1. Based on this analysis, the enzyme was successfully tested in the synthesis of 2-(6-hydroxynaphthyl) ß-d-xylopyranoside, a well-known selective anti-proliferative compound, enzymatically obtained for the first time. The application of response surface methodology, following a Box-Behnken design, enhanced this production by eightfold, fitting the reaction conditions into a multiparametric model. The naphthyl derivative was purified and its identity confirmed by NMR. [Conclusions]: A ß-xylosidase from T. amestolkiae was produced in P. pastoris and purified. The final yields were much higher than those attained for the native protein, although some loss of stability and maximum velocity was observed. rBxTW1 displayed remarkable acceptor versatility in transxylosylation, catalyzing the synthesis of a selective antiproliferative compound, 2-(6-hydroxynaphthyl) ß-d-xylopyranoside. These results evidence the interest of rBxTW1 for transxylosylation of relevant products with biotechnological interest.This work was carried out with funding from projects BIO2015-68387-R, RTC-2014-1777-3 and CTQ2015-64597-C2 from MINECO and S2013/MAE2972 from Comunidad de Madrid, as well as from the Natural Sciences and Engineering Research Council of Canada. M. Nieto-Domínguez thanks the MINECO for an FPU fellowship.We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI).Peer Reviewe

Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological products

[Abstract] Objective: The aim of this study was to explore perceptions of patients with rheumatic diseases treated with subcutaneous (SC) biological drugs on the impact on daily life and satisfaction with current therapy, including preferred attributes. Methods: A survey was developed ad hoc by four rheumatologists and three patients, including Likert questions on the impact of disease and treatment on daily life and preferred attributes of treatment. Rheumatologists from 50 participating centers were instructed to handout the survey to 20 consecutive patients with rheumatoid arthritis (RA), axial spondyloarthritis (ax-SpA), or psoriatic arthritis (PsA) receiving SC biological drugs. Patients responded to the survey at home and sent it to a central facility by prepaid mail. Results: A total of 592 patients returned the survey (response rate: 59.2%), 51.4% of whom had RA, 23.8% had ax-SpA, and 19.6% had PsA. Patients reported moderate-to-severe impact of their disease on their quality of life (QoL) (51.9%), work/daily activities (49.2%), emotional well-being (41.0%), personal relationships (26.0%), and close relatives’ life (32.3%); 30%–50% patients reported seldom/never being inquired about these aspects by their rheumatologists. Treatment attributes ranked as most important were the normalization of QoL (43.6%) and the relief from symptoms (35.2%). The satisfaction with their current antirheumatic therapy was high (>80% were “satisfied” or “very satisfied”), despite moderate/severe impact of disease. Conclusion: Patients with rheumatic diseases on SC biological therapy perceive a high disease impact on different aspects of daily life, despite being highly satisfied with their treatment; the perception is that physicians do not frequently address personal problems. Normalization of QoL is the most important attribute of therapies to patients

Análisis comparativo de las traducciones al castellano y al catalán de la novela 'The Slow Regard of Silent Things'

Anàlisi comparatiu de les traduccions al castellà i al català d'alguns elements especialment importants a la novel·la The Slow regard of Silent Things, de Patrick Rotfuss, un spin off de la trilogia The Kingkiller Chronicle, que té lloc a un món on les paraules, i sobretot els noms, tenen una importància molt gran. Anàlisi en conjunt de la versió original i les traduccions de cada element, reconstrucció del procés de traducció i cerca d'un mètode global i un possible paral·lelisme entre ambdues traduccions.Análisis comparativo de las traducciones al castellano y al catalán de algunos elementos de especial importancia en la novela The Slow regard of Silent Things, de Patrick Rothfuss, un spin off de la trilogía The Kingkiller Chronicle, que se desarrolla en un mundo en el que las palabras, sobre todo los nombres, tienen un gran peso. Análisis conjunto de la versión original y las traducciones de cada elemento, reconstrucción del proceso de traducción y búsqueda de un método global y de un posible paralelismo entre ambas traducciones.A comparative analysis of the Spanish and Catalan translations of some specially important items from the novel The Slow Regard of Silent Things, by Patrick Rothfuss, a spin off from the trilogy The Kingkiller Chronicle, a story that takes place in a world where words, specially names, have a great significance. Analysis of the original version and the translations together for each item, reconstruction of the translation process and search for a global translation method and the possible parallel between the analysed translations

Role of the oxygen partial pressure in the formation of composite Co-CoO nanoparticles by reactive aggregation

The magnetic properties of diluted films composed of nanocomposite Co-CoO nanoparticles (of ~8 nm diameter) dispersed in a Cu matrix have been investigated. The nanoparticles were formed in an aggregation chamber by sputtering at different Ar/O2 partial pressures (0-0.015). The exchange bias properties appear to be insensitive to the amount of O2 during their formation. However, the temperature dependence of the magnetization, M(T), exhibits two different contributions with relative intensities that correlate with the amount of O2. The magnetic results imply that two types of particles are formed, nanocomposite Co-CoO (determining the exchange bias) and pure CoO, as confirmed by transmission electron microscopy observations. Importantly, as the O2 partial pressure during the sputtering is raised the number of nanocomposite Co-CoO nanoparticles (exhibiting exchange bias properties) is reduced and, consequently, there is an increase in the relative amount of pure, antiferromagnetic CoO particles